SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject11/24/2000 11:19:30 PM
From: tuck   of 1784
 
Evening, Gang,

More pruning . . .

PKI is another one in which their trickle business is growing rapidly, but still seems to be under 50%. It is also quite expensive. It gets chucked.

PLL is a closer call, it would seem. Trickle is very close to even there. Nevertheless, if memory serves, competitor MIL is spinning off its life sciences unit early next year. That will likely be a much purer play in the filter segment. So PLL is getting chucked, too.

BDAL, OTOH, is definitely a pure play in the MS space. They are targeting life sciences exclusively. It stays, and moreover is very close to my buy target of 27.

Later, I'll look at some of the recent suggestions I haven't gotten to yet. Also, I have taken a stab at Trickle Taxonomy. Eyes getting tired now, but stay tuned. I'll put it up this weekend and let you folks dissect it.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext